HIV and the eye
| dc.contributor.author | Gichuhi, Stephen | |
| dc.contributor.author | Arunga, Simon | |
| dc.date.accessioned | 2023-03-22T17:53:27Z | |
| dc.date.available | 2023-03-22T17:53:27Z | |
| dc.date.issued | 2020 | |
| dc.description.abstract | The main ocular effects of HIV are related to immune suppression and impaired immune surveillance of tumours. HIV compromises cell-mediated immunity, thereby increasing the risk of infection with: • bacteria (e.g., those causing tuberculosis and syphilis) • fungi (e.g., Candida spp. and Cryptococcus spp.) • parasites (e.g., Toxoplasma gondii) • viruses (e.g., herpes zoster virus, human papillomavirus, Kaposi sarcoma-associated herpes virus, cytomegalovirus and Epstein-Barr virus). Patients with lower CD4 counts are more likely to have ocular manifestations1; however, use of antiretroviral therapy (ART) has modified the epidemiology of ocular manifestations and variations in the predominant subtype of HIV may also lead to geographical differences in eye disease. | en_US |
| dc.identifier.citation | Gichuhi, S., & Arunga, S. (2020). HIV and the eye. Community Eye Health, 33(108), 76. | en_US |
| dc.identifier.uri | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7205170/ | |
| dc.identifier.uri | https://nru.uncst.go.ug/handle/123456789/8278 | |
| dc.language.iso | en | en_US |
| dc.publisher | HIV | en_US |
| dc.subject | HIV | en_US |
| dc.subject | Eye | en_US |
| dc.title | HIV and the eye | en_US |
| dc.type | Article | en_US |